<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28615443</article-id>
<article-id pub-id-type="pmc">5535014</article-id>
<article-id pub-id-type="publisher-id">R116.767723</article-id>
<article-id pub-id-type="doi">10.1074/jbc.R116.767723</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Control of immune-mediated pathology via the aryl hydrocarbon receptor</article-title>
<alt-title alt-title-type="short">MINIREVIEW: AhR control of immune-mediated pathology</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wheeler</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>Veit</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="author-notes" rid="FN2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quintana</surname>
<given-names>Francisco J.</given-names>
</name>
<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/content/292/30/12383/suppl/DCAuthor_profile"></ext-link>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>3</sup>
</xref>
</contrib>
<aff id="aff1">From the <label>‡</label>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115 and </aff>
<aff id="aff2">the <label>§</label>The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>3</label> To whom correspondence should be addressed: <addr-line>Ann Romney Center for Neurologic Diseases, Harvard Medical School, 60 Fenwood Rd., Boston, MA 02115.</addr-line> E-mail: <email>fquintana@rics.bwh.harvard.edu</email>.</corresp>
<fn fn-type="supported-by" id="FN1">
<label>1</label>
<p>Supported by National Institutes of Health Grant T32CA207021.</p>
</fn>
<fn fn-type="supported-by" id="FN2">
<label>2</label>
<p>Supported by Mallinkrodt Pharmaceuticals Educational Grant A219074 and German Research Foundation Fellowship DFG RO4866 1/1.</p>
</fn>
<fn fn-type="edited-by">
<p>Edited by George M. Carman</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>28</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>292</volume>
<issue>30</issue>
<fpage>12383</fpage>
<lpage>12389</lpage>
<permissions>
<copyright-statement>© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc03017012383.pdf"></self-uri>
<abstract>
<p>Genetic and environmental factors contribute to the development of immune-mediated diseases. Although numerous genetic factors contributing to autoimmunity have been identified in recent years, our knowledge on environmental factors contributing to the pathogenesis of autoimmune diseases and the mechanisms involved is still limited. In this context, the diet, microbiome, geographical location, as well as environmental pollutants have been shown to modulate autoimmune disease development. These environmental factors interact with cellular components of the immune system in distinct and defined ways and can influence immune responses at the transcriptional and protein level. Moreover, endogenous metabolites generated from basic cellular processes such as glycolysis and oxidative phosphorylation also contribute to the shaping of the immune response. In this minireview, we highlight recent progress in our understanding of the modulation of the immune response by the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor whose activity is regulated by small molecules provided by diet, commensal flora, environmental pollutants, and metabolism. We focus on the role of AhR in integrating signals from the diet and the intestinal flora to modulate ongoing inflammation in the central nervous system, and we also discuss the potential therapeutic value of AhR agonists for multiple sclerosis and other autoimmune diseases.</p>
</abstract>
<kwd-group>
<kwd>aryl hydrocarbon receptor (AhR)</kwd>
<kwd>astrocyte</kwd>
<kwd>immunology</kwd>
<kwd>lymphocyte</kwd>
<kwd>neuroimmunology</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>
<institution-wrap>
<institution>National Institutes of Health
</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>T32CA207021</award-id>
<award-id>NS087867</award-id>
<award-id>ES025530</award-id>
<award-id>AI126880</award-id>
<award-id>AI093903</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>